NEW YORK and ENCINO, Calif., Dec. 1, 2015 /PRNewswire/ -- healtheo360®, a web portal for people living with chronic health conditions, and Vital Options International, a cancer communication, education and advocacy organization, today announced the launch of the Cancer Collaborative, a global information network providing live treatment news, policy updates, and support services to patients and caregivers via healtheo360's Internet, social media and broadcast channels.
healtheo360 Wellness Blog
Antibiotics are an important wonder-drug in the history of medicine. They can be life-savers but their misuse has far reaching and harmful effects in healthcare. One such chilling-effect is antibiotic resistance.
This quick guide shows how this affects you and also what you can do to help prevent antibiotic resistance.
Did you know that every 3 minutes someone in the US is diagnosed with blood cancer? The Leukemia & Lymphoma Society (LLS) is leading the way in funding research to advance breakthrough therapies and ensure access to treatments for blood cancers and improve the quality of life for patients and their families.
What is Blood cancer?
Justin Sullivan/Getty Images(NEW YORK) -- Marline Van Duyne almost underwent chemotherapy without knowing whether she was among the 80 percent of people with her type of breast cancer who don’t need it.
Keith Brofsky/Thinkstock(RIO DE JANEIRO) -- Researchers have made great strides in early detection and prevention for cervical cancer, the third-most common cancer in women, including the HPV vaccine. But with all the progress, there are still thousands of women with advanced disease, and the five-year survival rate for late-stage cervical cancer is 15 percent. That number may now climb dramatically, if the results of a trial for Erlotinib, now in its second phase, proves typical.
The standard care for advanced cervical cancer is chemo-radiation and Cisplatin, a nonspecific drug. Erlotinib, the epidermal growth factor receptor (EGFR) inhibitor, is a type of biologic medication targeting growth receptors in the cancerous cells -- they can’t grow and cancer recedes.
For the study, which is published in the journal Cancer, Brazilian researchers at the Instituto de Cancer in Rio de Janeiro conducted a small trial in 36 women with Stage II and III cervical cancer (which now has a survival rate of 40 percent). After 77 weeks of treatment, all but two patients saw a complete disappearance of the cancer. At two and three years out, 92 percent and 80 percent of women survived, respectively.
Side effects of Erlotinib were generally manageable with patients experiencing mostly rashes and diarrhea.
According to the study authors, this is the first study to show that a target agent has promising activity against locally advanced cervical cancer. Still, more research is needed as the data presented in the trial is only preliminary.
Copyright 2014 ABC News Radio
@JenArnoldMD/Twitter(HOUSTON) -- Just three weeks after she revealed she had a rare form of cancer, TV personality and neonatologist Jen Arnold has begun chemotherapy.
Courtesy Penn Vet Center(PHILADELPHIA) -- Sasha, a 13-year-old American bulldog, was expected to die within months after losing her leg and undergoing chemotherapy for osteosarcoma, the same bone cancer that robbed Ted Kennedy Jr. of his leg in 1973 when he was 12.